Your session is about to expire
← Back to Search
Contact Lens
e Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens for Myopia, Hyperopia, and Presbyopia
N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights
Study Summary
This trial evaluates the performance of a new daily disposable multifocal contact lens for current soft contact lens wearers.
Eligible Conditions
- Myopia, Hyperopia, and Presbyopia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of Subjects Agreeing With the Statement "Clear Vision: Near, Far, and In-between
Trial Design
1Treatment groups
Experimental Treatment
Group I: e Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact LensExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens
2022
N/A
~310
Find a Location
Who is running the clinical trial?
Bausch & Lomb IncorporatedLead Sponsor
251 Previous Clinical Trials
57,115 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You require a distance lens correction ranging from +3.00 to -6.00 diopters in each eye.Participants must possess the capability to utilize an internet connection for completing a web-based survey and should be equipped with the ability to receive text messages.If the doctor finds any eye problem that would make it difficult for you to wear contact lenses.You have a scar or abnormal blood vessels in the central part of your cornea, which is the clear covering of your eye. However, if you have a minor scar on the outer edges of your cornea that doesn't affect wearing contact lenses, you can still participate in the study.You are allergic to any of the ingredients used in the study products.You have worn your current lenses for a minimum of 12 hours per day, at least four days each week.You have presbyopia and need near vision correction with a lens strength of between +0.75 to +2.50 diopters in each eye.You have an ongoing eye condition.You have had any type of surgery on your cornea, like LASIK or other vision correction surgeries.Your vision cannot be improved to a certain level even with special contact lenses.You have a condition called amblyopia, which affects your vision.Participants must be capable of adhering to all study and treatment requirements, as well abstain from using any contact lenses apart from those provided for the duration of the research.You currently wear certain types of contact lenses that correct your vision.All participants must be 40 years or older and capable of providing voluntary, informed consent.You must be able to achieve visibility of 42 letters (0.1 logMAR) or better in both eyes after spherocylindrical refraction correction has been applied.You must have transparent central corneas and be devoid of any front segment disorders.You must have been wearing multifocal soft contact lenses for at least 6 months and be comfortable with them.You wear multifocal lenses in both of your eyes.
Research Study Groups:
This trial has the following groups:- Group 1: e Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Myopia, Hyperopia, and Presbyopia Patient Testimony for trial: Trial Name: NCT05660577 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still room for participants in this research experiment?
"Clinicaltrials.gov indicates that this medical trial is presently seeking candidates; the study was first posted on November 7th 2022 and underwent its most recent alteration on December 13th of the same year."
Answered by AI
In which geographic locations is the trial taking place?
"This investigation into the efficacy of this medication is being conducted at 20 different sites, such as Lee & Woo Optometry in San Francisco, Colorado, Chester T Roe III MD Prof LLC in Denver, Florida and Pearle Vision in Jacksonville Georgia."
Answered by AI
How many participants are being monitored in the current experiment?
"Affirmative. As per clinicaltrials.gov, this trial is currently recruiting patients since the initial post date of November 7th 2022; an update was made on December 13th 2022. This study requires 300 participants across 20 medical centres to be enrolled."
Answered by AI
Who else is applying?
What state do they live in?
Florida
Georgia
Other
Rhode Island
What site did they apply to?
Vision Health Institute
Kannarr EyeCare
Other
West Bay Eye Associates
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
3+
Why did patients apply to this trial?
I wore contact lenses for yours.
PatientReceived no prior treatments
What questions have other patients asked about this trial?
How much will I get paid?
PatientReceived 2+ prior treatments
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger